{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:10:00Z","timestamp":1773277800014,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Australas Phys Eng Sci Med"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1007\/bf03178671","type":"journal-article","created":{"date-parts":[[2009,12,25]],"date-time":"2009-12-25T03:53:56Z","timestamp":1261713236000},"page":"118-128","source":"Crossref","is-referenced-by-count":8,"title":["Radiation protection recommendations for I-131 thyrotoxicosis, thyroid cancer and phaeochromocytoma patients"],"prefix":"10.1007","volume":"27","author":[{"given":"S.","family":"Woodings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03178671_CR1","unstructured":"ARPANSA,Discharge of patients undergoing treatment with radioactive substances. Radiation Protection Series No. 4, 2002."},{"key":"BF03178671_CR2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1259\/0007-1285-43-511-479","volume":"43","author":"R. C. T. Buchan","year":"1970","unstructured":"Buchan, R. C. T. and Brindle, J. M.Radioiodine therapy to out-patients-the contamination hazard. Br J Radiol, 43: p. 479\u2013482, 1970.","journal-title":"Br J Radiol"},{"key":"BF03178671_CR3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00006231-199303000-00003","volume":"14","author":"M. J. O\u2019Doherty","year":"1993","unstructured":"O\u2019Doherty, M. J., et al.,Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosis. Nucl Med Commun, 14: p. 160\u2013168, 1993.","journal-title":"Nucl Med Commun"},{"key":"BF03178671_CR4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s002590050437","volume":"26","author":"C. Reiners","year":"1999","unstructured":"Reiners, C. and Lassmann, M.Radioiodine (131I) treatment of hyperthyroidism: radiation protection and quality assurance. Eur J Nucl Med, 26: p. 683\u2013685, 1999.","journal-title":"Eur J Nucl Med"},{"key":"BF03178671_CR5","volume-title":"Handbook of Health Physics and Radiological Health","year":"1998","unstructured":"Handbook of Health Physics and Radiological Health. 3rd ed, ed. B. Shleien, L.A. Slaback Jr, and B.K. Birky. Baltimore: Williams and Wilkins, 1998.","edition":"3rd ed"},{"key":"BF03178671_CR6","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s002590050438","volume":"26","author":"S. F. Barrington","year":"1999","unstructured":"Barrington, S. F., et al.,Radioactive exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. Eur J Nucl Med, 26: p. 686\u2013692, 1999.","journal-title":"Eur J Nucl Med"},{"key":"BF03178671_CR7","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s002590050310","volume":"25","author":"M. Monsieurs","year":"1998","unstructured":"Monsieurs, M., et al.,Real-life radiation burden to relatives of patients treated with iodine-131: a study in eight centres in Flanders (Belgium). Eur J Nucl Med, 25: p. 1368\u20131376, 1998.","journal-title":"Eur J Nucl Med"},{"key":"BF03178671_CR8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0140-6736(05)70454-2","volume":"350","author":"I. Mathieu","year":"1997","unstructured":"Mathieu, I., et al.,Doses in family members after 131I treatment. The Lancet, 350: p. 1074\u20131075, 1997.","journal-title":"The Lancet"},{"key":"BF03178671_CR9","first-page":"1402","volume":"33","author":"C. M. Culver","year":"1992","unstructured":"Culver, C. M. and Dworkin, H. J.Radiation safety considerations for post-iodine-131 thyroid cancer therapy. J Nucl Med, 33: p. 1402\u20131405, 1992.","journal-title":"J Nucl Med"},{"key":"BF03178671_CR10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01731834","volume":"23","author":"S. F. Barrington","year":"1996","unstructured":"Barrington, S. F., et al.,Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur J Nucl Med, 23: p. 123\u2013130, 1996.","journal-title":"Eur J Nucl Med"},{"key":"BF03178671_CR11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","volume":"22","author":"R. Nath","year":"1995","unstructured":"Nath, R., et al.,Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM radiation therapy committee task group no. 43. Med Phys, 22: p. 209\u2013234, 1995.","journal-title":"Med Phys"},{"key":"BF03178671_CR12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00006231-198711000-00002","volume":"8","author":"P. J. Mountford","year":"1987","unstructured":"Mountford, P. J.,Estimation of close contact doses to young infants from surface dose rates on radioactive adults. Nucl Med Commun, 8: p.857\u2013863, 1987.","journal-title":"Nucl Med Commun"},{"key":"BF03178671_CR13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1088\/0031-9155\/43\/3\/003","volume":"43","author":"J. omack","year":"1998","unstructured":"omack, J. and Shearer, J.Calculation of radiation exposures from patients to whom radioactive materials have been administered. Phys Med Biol, 43: p. 501\u2013516, 1998.","journal-title":"Phys Med Biol"},{"key":"BF03178671_CR14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00006231-199106000-00003","volume":"12","author":"T. E. Hilditch","year":"1991","unstructured":"Hilditch, T. E., et al.,Radiological protection guidance for radioactive patients-new data for therapeutic 131I. Nucl Med Commun, 12: p.485\u2013495, 1991.","journal-title":"Nucl Med Commun"},{"key":"BF03178671_CR15","first-page":"1","volume-title":"Radiation protection 97","author":"European Commission","year":"1998","unstructured":"European Commission,Radiation protection 97. Office for Official Publications of the European Communities: Luxembourg. p. 1\u201334, 1998."},{"key":"BF03178671_CR16","unstructured":"ICRP,Publication 60: 1990 Recommendations of the International Commission on Radiological Protection, ed. H. Smith., Pergamon Press, 1990:"},{"key":"BF03178671_CR17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00286779","volume":"14","author":"H. Wasserman","year":"1988","unstructured":"Wasserman, H. and Groenewald, W.Air kerma rate constants for radionuclides. Eur J Nucl Med, 14: p. 569\u2013571, 1988.","journal-title":"Eur J Nucl Med"},{"key":"BF03178671_CR18","volume-title":"ICRU Report 47 Measurement of Dose Equivalents from External Photon and Electron Radiations","author":"ICRU","year":"1992","unstructured":"ICRU,ICRU Report 47 Measurement of Dose Equivalents from External Photon and Electron Radiations, International Commission on Radiation Units and Measurements: Bethesda, USA, 1992."},{"key":"BF03178671_CR19","volume-title":"The development of a system to measure retained bodily activity after iodine-131 therapy","author":"J. W. Burrage","year":"1997","unstructured":"Burrage, J. W.,The development of a system to measure retained bodily activity after iodine-131 therapy. Royal Perth Hospital: Perth, Australia, 1997."},{"key":"BF03178671_CR20","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1002\/1097-0142(19901215)66:12<2509::AID-CNCR2820661211>3.0.CO;2-M","volume":"66","author":"D. W. Morrish","year":"1990","unstructured":"Morrish, D. W., et al.,131I treatment of thyroid papillary carcinoma in a patient with renal failure. Cancer, 66: p. 2509\u20132513, 1990.","journal-title":"Cancer"},{"key":"BF03178671_CR21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00006231-199309000-00004","volume":"14","author":"H. J. Wasserman","year":"1993","unstructured":"Wasserman, H. J. and Klopper, J. F.Analysis of radiation doses received by the public from 131I treatment of thyrotoxic outpatients. Nuc Med Commun, 14: p. 756\u2013760, 1993.","journal-title":"Nuc Med Commun"},{"key":"BF03178671_CR22","unstructured":"NCRP,Report No. 105. Bethesda USA, 1989."}],"container-title":["Australasian Physics &amp; Engineering Sciences in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03178671.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03178671\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03178671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T23:45:12Z","timestamp":1558482312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03178671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["BF03178671"],"URL":"https:\/\/doi.org\/10.1007\/bf03178671","relation":{},"ISSN":["0158-9938","1879-5447"],"issn-type":[{"value":"0158-9938","type":"print"},{"value":"1879-5447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}